Questions

What is meant by recombinant therapeutics?

What is meant by recombinant therapeutics?

Recombinant Therapeutics are therapeutic proteins produced by recombinant DNA technology. It includes Recombinant hormones, interferons, interleukins, hematopoietic growth factors, tumor necrosis factors, blood-clotting factors, thrombolytic drugs, enzymes, monoclonal antibodies and vaccines.

What are the advantages of recombinant therapeutics?

(a) Recombinant therapeutics are very effective and more potent. (b) The recombinant therapeutics are safe and do not induce unwanted immunological responses like similar products of non-human origin. About 30 recombinant therapeutics have been approved world over. 12 of them are being marketed in India.

How many recombinant therapeutics are approved?

So, at present, about 30 recombinant therapeutics have been approved for human use over the world.

What are proteins Therapeutics?

The term therapeutic protein was first used to describe medicines that are genetically engineered versions of naturally occurring human proteins. The complex structure of proteins can be represented in several different ways to help scientists study larger or smaller details of the molecule.

READ ALSO:   What is the difference between a stop sign and a stop light?

How many recombinant therapeutics are being marketed Currebtly in India?

12 recombinant therapeutics
In India, 12 recombinant therapeutics are presently being marketed.

Which human hormone was first produced by recombinant DNA technology?

human insulin
The first licensed drug generated using recombinant DNA technology was human insulin, developed by Genentech and licensed by Eli Lilly and Company.

Which recombinant protein is used in treatment of asthma?

Sodium cromoglycate probably has its major effect in chronic asthma management as a prophylactically anti-inflammatory asthma therapy by preventing all aspects of the allergen-induced asthmatic response [14].

How are protein therapeutics made?

Most proteins are produced using recombinant DNA technology using various host systems such as bacteria, yeast, insect cells, and mammalian cells. The host choice is dependent on the cost of production as well as the biological activities that are required for its production.